Testing for the presence of HLA-DR4 antigen in a patient is used to determine the potential risk of developing of Lyme arthritis from infection with Borrelia burgdorferi or vaccination with Lyme vaccine
Yellow ACD-B
Dk green heparin (Li or Na), no gel
Dk green heparin (Li or Na), no gel
Ambient (strict) - 72 hours
Refrigerated - NO
Frozen - NO
Flow Cytometry (FC)
Negative